Skip to content

AstroNova, Inc. ALOT Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

HP logo
HPHPQ
Avery Dennison logo
Avery DennisonAVY
AIRO Group Holdings, Inc. Common Stock logo
AIRO Group Holdings, Inc. Common StockAIRO
Crane Co. logo
Crane Co.CR
Ducommun logo
DucommunDCO
Veralto logo
VeraltoVLTO

Other financials

Income statement

See full
Revenue$39.4M+4.4%
Gross profit$14.4M+20.7%
Operating income$1.6M+174%
Net income$653.0K+274%
EPS (diluted)$0.08+260%

Balance sheet

See full
Cash & equivalents$4.7M-12.7%
Total debt$22.9M-1.3%
Total equity$77.5M+1.3%
Total assets$139.9M-7.0%

Cash flow

See full
Operating cash flow$3.0M-31.3%
CapEx$36.0K-40.0%
Free cash flow$3.0M-31.1%

Valuation

See full
Market cap$221.25M+214%
Enterprise value$239.45M+171%
P/S1.5×+1.0×

Profitability

See full
Gross margin32.5%0.0pp
Operating margin1.4%+0.8pp
Net margin-0.9%-0.4pp
FCF margin6.6%

Returns & leverage

See full
Return on equity-1.7%-0.8pp
Debt / equity0.3×0.0×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by AstroNova, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: AstroNova, Inc.’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AstroNova, Inc.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AstroNova, Inc.'s common stock, shares authorized (in shares)?
AstroNova, Inc. (ALOT) reported common stock, shares authorized (in shares) of $13M in Q1 2026.
How has AstroNova, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
AstroNova, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $13M to $13M.
What is the long-term trend for AstroNova, Inc.'s common stock, shares authorized (in shares)?
Over 5 years (2021 to 2026), AstroNova, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $13M to $13M.